1. National Heart and Lung Institute,
2. National Center for Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia;
3. Centre for Cardiovascular Medicine and Device Innovation, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom;
4. National Phenome Centre and Imperial Clinical Phenotyping Centre, and
5. Section of Bioanalytical Chemistry, Division of Systems Medicine, Department of Metabolism, Digestion, and Reproduction, and
6. Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular, and Integrative Biology, University of Liverpool, Liverpool, United Kingdom;
7. Mitochondrial Biology Unit, Medical Research Council, University of Cambridge, Cambridge, United Kingdom; and
8. Centre for Cell Signalling and Inflammation, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom;
9. Cell and Developmental Biology, University College London, London, United Kingdom